![Rainer C. Burian](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Rainer C. Burian
Keine laufenden Positionen mehr
Karriereverlauf von Rainer C. Burian
Ehemalige bekannte Positionen von Rainer C. Burian
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
APEIRON Biologics AG
![]() APEIRON Biologics AG BiotechnologyHealth Technology APEIRON Biologics AG operates as a clinical-stage company which engages in the discovery and development of novel cancer immunotherapies. The firm develops APN311, a therapeutic antibody to treat pediatric patients with neuroblastoma; APN301, an immunocytokine consisting of a humanized antibody genetically linked to two human IL-2 molecules; and APN401, a first-in-class autologous cellular therapy. The company was founded by Josef Penninger in 2005 and is headquartered in Vienna, Austria. | Direktor/Vorstandsmitglied | - | 21.06.2021 |
Statistik
International
Österreich | 2 |
Operativ
Director/Board Member | 1 |
Sektoral
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
APEIRON Biologics AG
![]() APEIRON Biologics AG BiotechnologyHealth Technology APEIRON Biologics AG operates as a clinical-stage company which engages in the discovery and development of novel cancer immunotherapies. The firm develops APN311, a therapeutic antibody to treat pediatric patients with neuroblastoma; APN301, an immunocytokine consisting of a humanized antibody genetically linked to two human IL-2 molecules; and APN401, a first-in-class autologous cellular therapy. The company was founded by Josef Penninger in 2005 and is headquartered in Vienna, Austria. | Health Technology |
- Börse
- Insiders
- Rainer C. Burian
- Erfahrung